##semicolon##
Болезнь Гиршпрунга, послеоперационный энтероколит, иммунологические детерминанты, TLR4, zonulin, sCD14, CD4/CD8, sIgA, прогнозирование осложнений.##submission.citations##
Amiel J., Lyonnet S. Hirschsprung disease, associated syndromes, and genetics: A review. J. Med. Genet. 2001; 38(11): 729–739.
Heuckeroth R.O. Hirschsprung disease — integrating basic science and clinical medicine to improve outcomes. Nat. Rev. Gastroenterol. Hepatol. 2018; 15(3): 152–167.
Kapoor A., et al. Immune dysregulation and enterocolitis in children with Hirschsprung disease. J. Pediatr. Surg. 2020; 55(4): 604–610.
Cheng W., et al. Hirschsprung-associated enterocolitis: pathogenesis, diagnosis, and management strategies. Pediatr. Surg. Int. 2017;33(10):1047–1056.
Austin K.M. The pathogenesis of Hir-schsprung-associated enterocolitis. Sem-in. Pediatr. Surg. 2012;21(4):319–327.
Frykman P.K., et al. Toll-like receptor pathways in Hirschsprung-associated enterocolitis. J. Pediatr. Surg. 2015; 50(1): 132–138.
Pini Prato A., et al. Long-term outcomes and risk factors of Hirschsprung-associated enterocolitis after pull-through surgery. Ann. Surg. 2019;270(3):610–618.
Yang M., et al. Zonulin as a biomarker of intestinal barrier dysfunction in pediatric surgical diseases. Clin. Chim. Acta. 2021; 5 14: 1–7.
Shen D.H., et al. Predictive value of inflammatory cytokines in postoperative enterocolitis in children with Hirschsprung disease. World J. Pediatr. 2020;16(3):262–269.
Schwengel D.A., et al. CD4/CD8 ratio disturbances and innate immune activation in complicated Hirschsprung disease. Pediatr. Res. 2016;80(5):745–752.